-
1
-
-
32944469988
-
Cost of moderate to severe plaque psoriasis in Germany: A multicenter cost-of-illness study
-
Sohn S, Schoeffski O, Prinz J, Reich K, Schubert E, Waldorf K, Augustin M: Cost of moderate to severe plaque psoriasis in Germany: a multicenter cost-of-illness study. Dermatology 2006;212:137-144.
-
(2006)
Dermatology
, vol.212
, pp. 137-144
-
-
Sohn, S.1
Schoeffski, O.2
Prinz, J.3
Reich, K.4
Schubert, E.5
Waldorf, K.6
Augustin, M.7
-
2
-
-
43049086525
-
-
Rychlik R, Wertheimer A, Rusche H, Augustin M, Nelles S, Böcking W: Policy decision making and outcomes research in drug utilization. Z Gesundheitswiss/J Public Health 2005;1:1-14.
-
Rychlik R, Wertheimer A, Rusche H, Augustin M, Nelles S, Böcking W: Policy decision making and outcomes research in drug utilization. Z Gesundheitswiss/J Public Health 2005;1:1-14.
-
-
-
-
3
-
-
0035069606
-
The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient-membership survey
-
Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T: The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001;137:280-284.
-
(2001)
Arch Dermatol
, vol.137
, pp. 280-284
-
-
Krueger, G.1
Koo, J.2
Lebwohl, M.3
Menter, A.4
Stern, R.S.5
Rolstad, T.6
-
4
-
-
1942537029
-
Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system
-
Augustin M, Lange S, Wenninger K, Seidenglanz K, Amon U, Zschocke I: Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system. Eur J Dermatol 2004;14:107-113.
-
(2004)
Eur J Dermatol
, vol.14
, pp. 107-113
-
-
Augustin, M.1
Lange, S.2
Wenninger, K.3
Seidenglanz, K.4
Amon, U.5
Zschocke, I.6
-
5
-
-
0036067321
-
Quality of life in 6,497 Nordic patients with psoriasis
-
Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mork C, Sigurgeirsson B: Quality of life in 6,497 Nordic patients with psoriasis. Br J Dermatol 2002;146:1006-1016.
-
(2002)
Br J Dermatol
, vol.146
, pp. 1006-1016
-
-
Zachariae, R.1
Zachariae, H.2
Blomqvist, K.3
Davidsson, S.4
Molin, L.5
Mork, C.6
Sigurgeirsson, B.7
-
6
-
-
21744441228
-
Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany
-
Berger K, Ehlken B, Kugland B, Augustin M: Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany. J Dtsch Dermatol Ges 2005;3:511-518.
-
(2005)
J Dtsch Dermatol Ges
, vol.3
, pp. 511-518
-
-
Berger, K.1
Ehlken, B.2
Kugland, B.3
Augustin, M.4
-
8
-
-
0029664491
-
Assessment of quality-of-life outcomes
-
Testa MA, Simonson DC: Assessment of quality-of-life outcomes. N Engl J Med 1996;334:835-840.
-
(1996)
N Engl J Med
, vol.334
, pp. 835-840
-
-
Testa, M.A.1
Simonson, D.C.2
-
9
-
-
34250805302
-
Role of depression in quality of life for patients with psoriasis
-
Schmitt JM, Ford DE: Role of depression in quality of life for patients with psoriasis. Dermatology 2007;215:17-27.
-
(2007)
Dermatology
, vol.215
, pp. 17-27
-
-
Schmitt, J.M.1
Ford, D.E.2
-
10
-
-
33847709065
-
Impairment of sexual life in patients with psoriasis
-
IDI Multipurpose Psoriasis Research on Vital Experiences investigators
-
Sampogna F, Gisondi P, Tabolli S, Abeni D, IDI Multipurpose Psoriasis Research on Vital Experiences investigators: Impairment of sexual life in patients with psoriasis. Dermatology 2007;214:144-150.
-
(2007)
Dermatology
, vol.214
, pp. 144-150
-
-
Sampogna, F.1
Gisondi, P.2
Tabolli, S.3
Abeni, D.4
-
11
-
-
0142151699
-
AAD consensus statement on psoriasis therapies
-
Callen JP, Krueger GG, Lebwohl M, McBurney EI, Mease P, Menter A, Paller AS, Pariser DM, Weinblatt M, Zimmerman G: AAD consensus statement on psoriasis therapies. J Am Acad Dermatol 2003;49:897-899.
-
(2003)
J Am Acad Dermatol
, vol.49
, pp. 897-899
-
-
Callen, J.P.1
Krueger, G.G.2
Lebwohl, M.3
McBurney, E.I.4
Mease, P.5
Menter, A.6
Paller, A.S.7
Pariser, D.M.8
Weinblatt, M.9
Zimmerman, G.10
-
12
-
-
0026877917
-
The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection
-
Ware JE Jr, Sherbourne CD: The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
-
(1992)
Med Care
, vol.30
, pp. 473-483
-
-
Ware Jr, J.E.1
Sherbourne, C.D.2
-
13
-
-
0027569430
-
The MOS 36-Item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
-
McHorney CA, Ware JE Jr, Raczek AE: The MOS 36-Item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263.
-
(1993)
Med Care
, vol.31
, pp. 247-263
-
-
McHorney, C.A.1
Ware Jr, J.E.2
Raczek, A.E.3
-
14
-
-
0034922729
-
EQ-5D: A measure of health status from the EuroQol Group
-
Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-343.
-
(2001)
Ann Med
, vol.33
, pp. 337-343
-
-
Rabin, R.1
de Charro, F.2
-
15
-
-
0028332995
-
Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use
-
Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-216.
-
(1994)
Clin Exp Dermatol
, vol.19
, pp. 210-216
-
-
Finlay, A.Y.1
Khan, G.K.2
-
16
-
-
0032740427
-
Quality of life in skin diseases: Methodological and practical comparison of different quality of life questionnaires in psoriasis and atopic dermatitis
-
Augustin M, Zschocke I, Lange S, Seidenglanz K, Amon U: Quality of life in skin diseases: methodological and practical comparison of different quality of life questionnaires in psoriasis and atopic dermatitis. Hautarzt 1999;50:715-722.
-
(1999)
Hautarzt
, vol.50
, pp. 715-722
-
-
Augustin, M.1
Zschocke, I.2
Lange, S.3
Seidenglanz, K.4
Amon, U.5
-
18
-
-
22144483464
-
Two decades experience of the Psoriasis Disability Index
-
Lewis VJ, Finlay AY: Two decades experience of the Psoriasis Disability Index. Dermatology 2005;210:261-268.
-
(2005)
Dermatology
, vol.210
, pp. 261-268
-
-
Lewis, V.J.1
Finlay, A.Y.2
-
19
-
-
0026744242
-
Quality of life measures in health care. I. Applications and issues in assessment
-
Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D: Quality of life measures in health care. I. Applications and issues in assessment. BMJ 1992;305:1074-1077.
-
(1992)
BMJ
, vol.305
, pp. 1074-1077
-
-
Fitzpatrick, R.1
Fletcher, A.2
Gore, S.3
Jones, D.4
Spiegelhalter, D.5
Cox, D.6
-
20
-
-
0026540346
-
Quality of life measures in health care. III. Resource allocation
-
Spiegelhalter DJ, Gore SM, Fitzpatrick R, Fletcher AE, Jones DR, Cox D: Quality of life measures in health care. III. Resource allocation. BMJ 1992;305:1205-1209.
-
(1992)
BMJ
, vol.305
, pp. 1205-1209
-
-
Spiegelhalter, D.J.1
Gore, S.M.2
Fitzpatrick, R.3
Fletcher, A.E.4
Jones, D.R.5
Cox, D.6
-
21
-
-
0029888555
-
Assessment of values, utilities and preferences in cancer patients
-
de Haes JC, Stiggelbout AM: Assessment of values, utilities and preferences in cancer patients. Cancer Treat Rev 1996;22:13-26.
-
(1996)
Cancer Treat Rev
, vol.22
, pp. 13-26
-
-
de Haes, J.C.1
Stiggelbout, A.M.2
-
22
-
-
0036621075
-
The direct cost of care for psoriasis and psoriatic arthritis in the United States
-
Javitz HS, Ward MM, Farber E, Nail L, Vallow SG: The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol 2002;46:850-860.
-
(2002)
J Am Acad Dermatol
, vol.46
, pp. 850-860
-
-
Javitz, H.S.1
Ward, M.M.2
Farber, E.3
Nail, L.4
Vallow, S.G.5
-
23
-
-
0028893982
-
Trivial or terrible? The psychosocial impact of psoriasis
-
Fried RG, Friedman S, Paradis C, Hatch M, Lynfield Y, Duncanson C, Shalita A: Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol 1995;34:101-105.
-
(1995)
Int J Dermatol
, vol.34
, pp. 101-105
-
-
Fried, R.G.1
Friedman, S.2
Paradis, C.3
Hatch, M.4
Lynfield, Y.5
Duncanson, C.6
Shalita, A.7
-
24
-
-
33747081908
-
Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis
-
Schmitt RG, Ford DE: Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis. Dermatology 2006;213:102-110.
-
(2006)
Dermatology
, vol.213
, pp. 102-110
-
-
Schmitt, R.G.1
Ford, D.E.2
-
25
-
-
33748448266
-
EUROPSO Patient Survey Group: European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey
-
Dubertret L, Mrowietz U, Ranki A, van de Kerkhof PC, Chimenti S, Lotti T, Schäfer G; EUROPSO Patient Survey Group: European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006;155:729-736.
-
(2006)
Br J Dermatol
, vol.155
, pp. 729-736
-
-
Dubertret, L.1
Mrowietz, U.2
Ranki, A.3
van de Kerkhof, P.C.4
Chimenti, S.5
Lotti, T.6
Schäfer, G.7
-
26
-
-
1842555395
-
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction
-
Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T: Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004;9:136-139.
-
(2004)
J Investig Dermatol Symp Proc
, vol.9
, pp. 136-139
-
-
Stern, R.S.1
Nijsten, T.2
Feldman, S.R.3
Margolis, D.J.4
Rolstad, T.5
-
27
-
-
20444502501
-
Involving the patient: Impact of inflammatory skin disease and patient-focused care
-
Feldman S, Behnam SM, Behnam SE, Koo JY: Involving the patient: impact of inflammatory skin disease and patient-focused care. J Am Acad Dermatol 2005;53:78-85.
-
(2005)
J Am Acad Dermatol
, vol.53
, pp. 78-85
-
-
Feldman, S.1
Behnam, S.M.2
Behnam, S.E.3
Koo, J.Y.4
-
29
-
-
33751545239
-
S3 guidelines for the therapy of psoriasis vulgaris
-
Nast A, Kopp IB, Augustin M, Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mrowietz U, Ockenfels HM, Orzechowski HD, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B: S3 guidelines for the therapy of psoriasis vulgaris. J Dtsch Dermatol Ges 2006;4(suppl 2):S1-S126.
-
(2006)
J Dtsch Dermatol Ges
, vol.4
, Issue.SUPPL. 2
-
-
Nast, A.1
Kopp, I.B.2
Augustin, M.3
Banditt, K.B.4
Boehncke, W.H.5
Follmann, M.6
Friedrich, M.7
Huber, M.8
Kahl, C.9
Klaus, J.10
Koza, J.11
Kreiselmaier, I.12
Mohr, J.13
Mrowietz, U.14
Ockenfels, H.M.15
Orzechowski, H.D.16
Prinz, J.17
Reich, K.18
Rosenbach, T.19
Rosumeck, S.20
Schlaeger, M.21
Schmid-Ott, G.22
Sebastian, M.23
Streit, V.24
Weberschock, T.25
Rzany, B.26
more..
-
30
-
-
0018768940
-
Oral treatment of pustulosis palmo-plantaris with a new retinoid, Ro 10-9359
-
Fredriksson T, Pettersson U: Oral treatment of pustulosis palmo-plantaris with a new retinoid, Ro 10-9359. Dermatologica 1979;158:60-64.
-
(1979)
Dermatologica
, vol.158
, pp. 60-64
-
-
Fredriksson, T.1
Pettersson, U.2
-
31
-
-
17244369068
-
The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis
-
Schmitt J, Wozel G: The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 2005;210:194-199.
-
(2005)
Dermatology
, vol.210
, pp. 194-199
-
-
Schmitt, J.1
Wozel, G.2
-
33
-
-
0141927377
-
A single European currency for EQ-5D health states. Results from a sixcountry study
-
Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Kind P, Krabbe P, Ohinmaa A, Parkin D, Roset M, Sintonen H, Tsuchiya A, de Charro F: A single European currency for EQ-5D health states. Results from a sixcountry study. Eur J Health Econ 2003;4:222-231.
-
(2003)
Eur J Health Econ
, vol.4
, pp. 222-231
-
-
Greiner, W.1
Weijnen, T.2
Nieuwenhuizen, M.3
Oppe, S.4
Badia, X.5
Busschbach, J.6
Buxton, M.7
Dolan, P.8
Kind, P.9
Krabbe, P.10
Ohinmaa, A.11
Parkin, D.12
Roset, M.13
Sintonen, H.14
Tsuchiya, A.15
de Charro, F.16
-
35
-
-
43049139372
-
A review of the literature for nail psoriasis
-
Wang K, Spuls P: A review of the literature for nail psoriasis. Psoriasis Forum 2005;11:12-14.
-
(2005)
Psoriasis Forum
, vol.11
, pp. 12-14
-
-
Wang, K.1
Spuls, P.2
-
37
-
-
0028918535
-
The effect of severe psoriasis on the quality of life of 369 patients
-
Finlay AY, Coles EC: The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-244.
-
(1995)
Br J Dermatol
, vol.132
, pp. 236-244
-
-
Finlay, A.Y.1
Coles, E.C.2
-
38
-
-
0034664843
-
The psychosocial impact of psoriasis: Physical severity, quality of life, and stigmatization
-
Perrott SB, Murray AH, Lowe J, Mathieson CM: The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiol Behav 2000;70:567-571.
-
(2000)
Physiol Behav
, vol.70
, pp. 567-571
-
-
Perrott, S.B.1
Murray, A.H.2
Lowe, J.3
Mathieson, C.M.4
-
39
-
-
0035064793
-
The contribution of perceptions of stigmatisation to disability in patients with psoriasis
-
Richards HL, Fortune DG, Griffiths CE, Main CJ: The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001;50:11-15.
-
(2001)
J Psychosom Res
, vol.50
, pp. 11-15
-
-
Richards, H.L.1
Fortune, D.G.2
Griffiths, C.E.3
Main, C.J.4
-
40
-
-
0035724829
-
Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin
-
Touw CR, Hakkaart-Van Roijen L, Verboom P, Paul C, Rutten FF, Finlay AY: Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 2001;144:967-972.
-
(2001)
Br J Dermatol
, vol.144
, pp. 967-972
-
-
Touw, C.R.1
Hakkaart-Van Roijen, L.2
Verboom, P.3
Paul, C.4
Rutten, F.F.5
Finlay, A.Y.6
-
41
-
-
17144379311
-
Health status of the German population: Results of a representative survey using the EuroQol questionnaire
-
Konig HH, Bernert S, Angermeyer MC: Health status of the German population: results of a representative survey using the EuroQol questionnaire. Gesundheitswesen 2005;67:173-182.
-
(2005)
Gesundheitswesen
, vol.67
, pp. 173-182
-
-
Konig, H.H.1
Bernert, S.2
Angermeyer, M.C.3
-
42
-
-
43049125670
-
Use in Germany (Arzneiverordnungsreport 2006)
-
Schwabe U, Paffrath D eds, Heidelberg, Springer
-
Schwabe U, Paffrath D (eds): Report on the Drug Use in Germany (Arzneiverordnungsreport 2006). Heidelberg, Springer, 2006.
-
(2006)
Report on the Drug
-
-
|